Page last updated: 2024-10-21

1-anilino-8-naphthalenesulfonate and Short Bowel Syndrome

1-anilino-8-naphthalenesulfonate has been researched along with Short Bowel Syndrome in 3 studies

1-anilino-8-naphthalenesulfonate: RN given refers to parent cpd
8-anilinonaphthalene-1-sulfonic acid : A naphthalenesulfonic acid that is naphthalene-1-sulfonic acid substituted by a phenylamino group at position 8.

Short Bowel Syndrome: A malabsorption syndrome resulting from extensive operative resection of the SMALL INTESTINE, the absorptive region of the GASTROINTESTINAL TRACT.

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19901 (33.33)18.7374
1990's2 (66.67)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Navab, F1
O'Keefe, SJ1
Haymond, MW1
Bennet, WM1
Oswald, B1
Nelson, DK1
Shorter, RG1
Hardt, PD1
Helfrich, C1
Klauke, T1
Klör, HU1

Other Studies

3 other studies available for 1-anilino-8-naphthalenesulfonate and Short Bowel Syndrome

ArticleYear
Management of short-bowel syndrome.
    Southern medical journal, 1984, Volume: 77, Issue:4

    Topics: Adaptation, Physiological; Anti-Bacterial Agents; Crohn Disease; Diet; Fluid Therapy; Humans; Intest

1984
Long-acting somatostatin analogue therapy and protein metabolism in patients with jejunostomies.
    Gastroenterology, 1994, Volume: 107, Issue:2

    Topics: Adult; Aged; Amino Acids; Amylases; Delayed-Action Preparations; Female; Gastric Acid; Gastrointesti

1994
Liquid pancreatic enzyme therapy for a patient with short bowel syndrome and chronic pancreatitis in a complicated case of Crohn's disease.
    European journal of medical research, 1999, Aug-25, Volume: 4, Issue:8

    Topics: Chronic Disease; Crohn Disease; Enteral Nutrition; Female; Humans; Immunosuppressive Agents; Lipase;

1999